PubMed:8978306
Annnotations
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-72 | Sentence | denotes | Engagement of the Lewis X antigen (CD15) results in monocyte activation. |
| T2 | 73-248 | Sentence | denotes | We previously reported that monocyte adhesion to tumor necrosis factor-alpha (TNF-alpha)-treated endothelial cells increased expression of tissue factor and CD36 on monocytes. |
| T3 | 249-452 | Sentence | denotes | Using immunological cross-linking to mimic receptor engagement by natural ligands, we now show that CD15 (Lewis X), a monocyte counter-receptor for endothelial selectins may participate in this response. |
| T4 | 453-653 | Sentence | denotes | We used cytokine production as a readout for monocyte activation and found that CD15 cross-linking induced TNF-alpha release from peripheral blood monocytes and cells from the monocytic cell line MM6. |
| T5 | 654-810 | Sentence | denotes | Quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) showed an increase in steady-state TNF-alpha mRNA after 3 to 4 hours of cross-linking. |
| T6 | 811-991 | Sentence | denotes | CD15 cross-linking also concomitantly increased interleukin-1 beta (IL-1 beta) mRNA, while no apparent change was observed in the levels of beta-actin mRNA, indicating specificity. |
| T7 | 992-1174 | Sentence | denotes | To examine transcriptional regulation of cytokine genes by CD15 engagement, a CAT plasmid reporter construct containing IL-1 beta promoter/enhancer sequences was introduced into MM6. |
| T8 | 1175-1231 | Sentence | denotes | Subsequent cross-linking of CD15 increased CAT activity. |
| T9 | 1232-1396 | Sentence | denotes | CD15 engagement by monoclonal antibody also attenuated IL-1 beta transcript degradation, demonstrating that signaling via CD15 also had posttranscriptional effects. |
| T10 | 1397-1620 | Sentence | denotes | Nuclear extracts of anti-CD15 cross-linked cells demonstrated enhanced levels of the transcriptional factor activator protein-1, minimally changed nuclear factor-kappa B, and did not affect SV40 promoter specific protein-1. |
| T11 | 1621-1701 | Sentence | denotes | We conclude that engagement of CD15 on monocytes results in monocyte activation. |
| T12 | 1702-1913 | Sentence | denotes | In addition to its well-recognized adhesive role, CD15 may function as an important signaling molecule capable of initiating proinflammatory events in monocytes that come into contact with activated endothelium. |
| T1 | 0-72 | Sentence | denotes | Engagement of the Lewis X antigen (CD15) results in monocyte activation. |
| T2 | 73-248 | Sentence | denotes | We previously reported that monocyte adhesion to tumor necrosis factor-alpha (TNF-alpha)-treated endothelial cells increased expression of tissue factor and CD36 on monocytes. |
| T3 | 249-452 | Sentence | denotes | Using immunological cross-linking to mimic receptor engagement by natural ligands, we now show that CD15 (Lewis X), a monocyte counter-receptor for endothelial selectins may participate in this response. |
| T4 | 453-653 | Sentence | denotes | We used cytokine production as a readout for monocyte activation and found that CD15 cross-linking induced TNF-alpha release from peripheral blood monocytes and cells from the monocytic cell line MM6. |
| T5 | 654-810 | Sentence | denotes | Quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) showed an increase in steady-state TNF-alpha mRNA after 3 to 4 hours of cross-linking. |
| T6 | 811-991 | Sentence | denotes | CD15 cross-linking also concomitantly increased interleukin-1 beta (IL-1 beta) mRNA, while no apparent change was observed in the levels of beta-actin mRNA, indicating specificity. |
| T7 | 992-1174 | Sentence | denotes | To examine transcriptional regulation of cytokine genes by CD15 engagement, a CAT plasmid reporter construct containing IL-1 beta promoter/enhancer sequences was introduced into MM6. |
| T8 | 1175-1231 | Sentence | denotes | Subsequent cross-linking of CD15 increased CAT activity. |
| T9 | 1232-1396 | Sentence | denotes | CD15 engagement by monoclonal antibody also attenuated IL-1 beta transcript degradation, demonstrating that signaling via CD15 also had posttranscriptional effects. |
| T10 | 1397-1620 | Sentence | denotes | Nuclear extracts of anti-CD15 cross-linked cells demonstrated enhanced levels of the transcriptional factor activator protein-1, minimally changed nuclear factor-kappa B, and did not affect SV40 promoter specific protein-1. |
| T11 | 1621-1701 | Sentence | denotes | We conclude that engagement of CD15 on monocytes results in monocyte activation. |
| T12 | 1702-1913 | Sentence | denotes | In addition to its well-recognized adhesive role, CD15 may function as an important signaling molecule capable of initiating proinflammatory events in monocytes that come into contact with activated endothelium. |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 122-187 | cell_line | denotes | tumor necrosis factor-alpha (TNF-alpha)-treated endothelial cells |
| T2 | 230-234 | protein | denotes | CD36 |
| T3 | 367-392 | protein | denotes | monocyte counter-receptor |
| T4 | 397-418 | protein | denotes | endothelial selectins |
| T5 | 560-569 | protein | denotes | TNF-alpha |
| T6 | 583-609 | cell_type | denotes | peripheral blood monocytes |
| T7 | 629-652 | cell_line | denotes | monocytic cell line MM6 |
| T8 | 667-688 | protein | denotes | reverse transcriptase |
| T9 | 759-773 | RNA | denotes | TNF-alpha mRNA |
| T10 | 859-894 | RNA | denotes | interleukin-1 beta (IL-1 beta) mRNA |
| T11 | 951-966 | RNA | denotes | beta-actin mRNA |
| T12 | 1033-1047 | DNA | denotes | cytokine genes |
| T13 | 1112-1149 | DNA | denotes | IL-1 beta promoter/enhancer sequences |
| T14 | 1170-1173 | cell_line | denotes | MM6 |
| T15 | 1218-1221 | protein | denotes | CAT |
| T16 | 1251-1270 | protein | denotes | monoclonal antibody |
| T17 | 1287-1296 | protein | denotes | IL-1 beta |
| T18 | 1422-1445 | cell_type | denotes | CD15 cross-linked cells |
| T19 | 1482-1524 | protein | denotes | transcriptional factor activator protein-1 |
| T20 | 1544-1566 | protein | denotes | nuclear factor-kappa B |
| T21 | 1587-1619 | protein | denotes | SV40 promoter specific protein-1 |
| T22 | 1853-1862 | cell_type | denotes | monocytes |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-72 | Sentence | denotes | Engagement of the Lewis X antigen (CD15) results in monocyte activation. |
| S2 | 73-248 | Sentence | denotes | We previously reported that monocyte adhesion to tumor necrosis factor-alpha (TNF-alpha)-treated endothelial cells increased expression of tissue factor and CD36 on monocytes. |
| S3 | 249-452 | Sentence | denotes | Using immunological cross-linking to mimic receptor engagement by natural ligands, we now show that CD15 (Lewis X), a monocyte counter-receptor for endothelial selectins may participate in this response. |
| S4 | 453-653 | Sentence | denotes | We used cytokine production as a readout for monocyte activation and found that CD15 cross-linking induced TNF-alpha release from peripheral blood monocytes and cells from the monocytic cell line MM6. |
| S5 | 654-810 | Sentence | denotes | Quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) showed an increase in steady-state TNF-alpha mRNA after 3 to 4 hours of cross-linking. |
| S6 | 811-991 | Sentence | denotes | CD15 cross-linking also concomitantly increased interleukin-1 beta (IL-1 beta) mRNA, while no apparent change was observed in the levels of beta-actin mRNA, indicating specificity. |
| S7 | 992-1174 | Sentence | denotes | To examine transcriptional regulation of cytokine genes by CD15 engagement, a CAT plasmid reporter construct containing IL-1 beta promoter/enhancer sequences was introduced into MM6. |
| S8 | 1175-1231 | Sentence | denotes | Subsequent cross-linking of CD15 increased CAT activity. |
| S9 | 1232-1396 | Sentence | denotes | CD15 engagement by monoclonal antibody also attenuated IL-1 beta transcript degradation, demonstrating that signaling via CD15 also had posttranscriptional effects. |
| S10 | 1397-1620 | Sentence | denotes | Nuclear extracts of anti-CD15 cross-linked cells demonstrated enhanced levels of the transcriptional factor activator protein-1, minimally changed nuclear factor-kappa B, and did not affect SV40 promoter specific protein-1. |
| S11 | 1621-1701 | Sentence | denotes | We conclude that engagement of CD15 on monocytes results in monocyte activation. |
| S12 | 1702-1913 | Sentence | denotes | In addition to its well-recognized adhesive role, CD15 may function as an important signaling molecule capable of initiating proinflammatory events in monocytes that come into contact with activated endothelium. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C2 | 14-40 | NP | denotes | the Lewis X antigen (CD15) |
| C1 | 0-40 | NP | denotes | Engagement of the Lewis X antigen (CD15) |
| C3 | 52-71 | NP | denotes | monocyte activation |
| C4 | 238-247 | NP | denotes | monocytes |
| C5 | 349-363 | NP | denotes | CD15 (Lewis X) |
| C6 | 365-418 | NP | denotes | a monocyte counter-receptor for endothelial selectins |
| C7 | 498-517 | NP | denotes | monocyte activation |
| C8 | 533-551 | NP | denotes | CD15 cross-linking |
| C9 | 625-652 | NP | denotes | the monocytic cell line MM6 |
| C10 | 811-829 | NP | denotes | CD15 cross-linking |
| C11 | 1051-1066 | NP | denotes | CD15 engagement |
| C12 | 1170-1173 | NP | denotes | MM6 |
| C13 | 1203-1207 | NP | denotes | CD15 |
| C14 | 1232-1247 | NP | denotes | CD15 engagement |
| C15 | 1354-1358 | NP | denotes | CD15 |
| C17 | 1652-1656 | NP | denotes | CD15 |
| C16 | 1638-1656 | NP | denotes | engagement of CD15 |
| C18 | 1660-1669 | NP | denotes | monocytes |
| C19 | 1681-1700 | NP | denotes | monocyte activation |
| C20 | 1717-1720 | NP | denotes | its |
| C21 | 1752-1756 | NP | denotes | CD15 |
| C22 | 1853-1862 | NP | denotes | monocytes |
| C23 | 1863-1867 | NP | denotes | that |
| R1 | C5 | C2 | coref-ident | CD15 (Lewis X),the Lewis X antigen (CD15) |
| R2 | C6 | C5 | coref-appos | a monocyte counter-receptor for endothelial selectins,CD15 (Lewis X) |
| R3 | C7 | C3 | coref-ident | monocyte activation,monocyte activation |
| R4 | C10 | C8 | coref-ident | CD15 cross-linking,CD15 cross-linking |
| R5 | C11 | C1 | coref-ident | CD15 engagement,Engagement of the Lewis X antigen (CD15) |
| R6 | C12 | C9 | coref-ident | MM6,the monocytic cell line MM6 |
| R7 | C13 | C5 | coref-ident | CD15,CD15 (Lewis X) |
| R8 | C14 | C11 | coref-ident | CD15 engagement,CD15 engagement |
| R9 | C15 | C13 | coref-ident | CD15,CD15 |
| R10 | C17 | C15 | coref-ident | CD15,CD15 |
| R11 | C16 | C14 | coref-ident | engagement of CD15,CD15 engagement |
| R12 | C18 | C4 | coref-ident | monocytes,monocytes |
| R13 | C19 | C7 | coref-ident | monocyte activation,monocyte activation |
| R14 | C20 | C17 | coref-pron | its,CD15 |
| R15 | C21 | C17 | coref-ident | CD15,CD15 |
| R16 | C23 | C22 | coref-relat | that,monocytes |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 18-33 | carbohydrate | denotes | Lewis X antigen |
| T2 | 35-39 | carbohydrate | denotes | CD15 |
| T3 | 52-71 | other_name | denotes | monocyte activation |
| T4 | 122-151 | cell_line | denotes | tumor necrosis factor-alpha ( |
| T5 | 151-160 | protein_molecule | denotes | TNF-alpha |
| T6 | 170-187 | cell_type | denotes | endothelial cells |
| T7 | 230-234 | protein_molecule | denotes | CD36 |
| T8 | 349-353 | carbohydrate | denotes | CD15 |
| T9 | 355-362 | carbohydrate | denotes | Lewis X |
| T10 | 367-392 | protein_molecule | denotes | monocyte counter-receptor |
| T11 | 397-418 | protein_family_or_group | denotes | endothelial selectins |
| T12 | 498-517 | other_name | denotes | monocyte activation |
| T13 | 533-537 | carbohydrate | denotes | CD15 |
| T14 | 560-569 | protein_molecule | denotes | TNF-alpha |
| T15 | 583-609 | cell_type | denotes | peripheral blood monocytes |
| T16 | 629-652 | cell_line | denotes | monocytic cell line MM6 |
| T17 | 667-688 | protein_molecule | denotes | reverse transcriptase |
| T18 | 716-722 | other_name | denotes | RT-PCR |
| T19 | 759-768 | protein_molecule | denotes | TNF-alpha |
| T20 | 811-815 | carbohydrate | denotes | CD15 |
| T21 | 859-877 | protein_molecule | denotes | interleukin-1 beta |
| T22 | 879-888 | protein_molecule | denotes | IL-1 beta |
| T23 | 951-966 | RNA_molecule | denotes | beta-actin mRNA |
| T24 | 1033-1047 | DNA_family_or_group | denotes | cytokine genes |
| T25 | 1051-1055 | carbohydrate | denotes | CD15 |
| T26 | 1112-1121 | protein_molecule | denotes | IL-1 beta |
| T27 | 1170-1173 | cell_line | denotes | MM6 |
| T28 | 1203-1207 | carbohydrate | denotes | CD15 |
| T29 | 1218-1221 | protein_molecule | denotes | CAT |
| T30 | 1232-1236 | carbohydrate | denotes | CD15 |
| T31 | 1251-1270 | protein_family_or_group | denotes | monoclonal antibody |
| T32 | 1287-1296 | protein_molecule | denotes | IL-1 beta |
| T33 | 1354-1358 | carbohydrate | denotes | CD15 |
| T34 | 1368-1395 | other_name | denotes | posttranscriptional effects |
| T35 | 1422-1426 | carbohydrate | denotes | CD15 |
| T36 | 1482-1524 | protein_molecule | denotes | transcriptional factor activator protein-1 |
| T37 | 1544-1566 | protein_complex | denotes | nuclear factor-kappa B |
| T38 | 1587-1600 | DNA_domain_or_region | denotes | SV40 promoter |
| T39 | 1652-1656 | carbohydrate | denotes | CD15 |
| T40 | 1681-1700 | other_name | denotes | monocyte activation |
| T41 | 1752-1756 | carbohydrate | denotes | CD15 |
| T42 | 1827-1849 | other_name | denotes | proinflammatory events |
| T43 | 1853-1862 | cell_type | denotes | monocytes |
| T44 | 1891-1912 | tissue | denotes | activated endothelium |